CLINICAL_TRIALS
research
· 2025-03-06
Clinical Trial Update: Construct Validity and Responsiveness of EQ-5D-3L in Patients With Rheumatic Disease
Summary
A completed study evaluating the construct validity and responsiveness of the EQ-5D-3L health-status instrument in patients with rheumatic diseases.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Karolinska Institutet | Conditions: Rheumatoid Arthritis, Polyarthritis | Status: COMPLETED